Advertisement
Advertisement
January 21, 2020
SoundBite Crossing System for Treating Peripheral CTOs Receives FDA Clearance
January 21, 2020—SoundBite Medical Solutions Inc. announced it has received FDA 510(k) clearance for the SoundBite crossing system with active wire technology for use in the treatment of peripheral chronic total occlusions.
According to the company, which is based in Montreal, Quebec, the SoundBite technology is designed to deliver high-amplitude shock wave pulses in a controllable manner through guidewires and other interventional tools to specifically attack highly calcified and fibrotic tissue in the vascular system while leaving healthy, elastic arterial walls unharmed.
Advertisement
Advertisement